World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Article
U.S. Drug Companies Chase Vaccines
Keywords:
Tags:
Thre drug companies are placing bets on the vaccine business. Johnson and Johnson paid 302 million euros for 18% of Dutch biotech company Crucell NV, to jointly develop vaccines. Abbott Labs says it will acquire a unit of Belgian conglomerate Solvay SA for 4.5 billion euros in adeal that includes a vaccine business. And Merck obtained the marketing rights for a seasonal flu vaccine from Australia's CSL Ltd. This follows Pfizer's Wyeth acquisition. Low prices, high costs and fear of lawsuits made most drug makers to exit the business in the 1980's and 1990's. Now vaccine sales are growing faster than other prescription drugs and are largely protected from generic competition. And government agencies here in the USA and around the world are reliable buyers of vaccines as they seek to stockpile medicines that could be needed in aflu outbreak. Merck never exit the vaccine business and now makes 8 of 10 vaccines recommended for adults. Flu and other vaccines are especially attractive for entering drug markets in Brazil and China and developing countries. Governments lke the idea of lowcost prevention at $10 adose, and with this new relationships are developed in these countries. And even at price of $10 or $20 a dose they provide asteady stream of revenue.Vaccines are estimated to generate $21.5 billion in revenues by 2012 according to Sanofi-Aventis SA, which is a leading vaccine maker.
Changing marketing landscape for Drug Companies
10/02/2006
Controversial practices of some companies, Changes in the marketing strategies and practices of companies like Pfizer.
Grouped Articles
Glaxo Epilepsy Drug Is Linked to Defects Found in Newborns - WSJ.com
Wall Street Journal 10/02/2006
How Glaxo Marketed a Malady to Sell a Drug - WSJ.com
Wall Street Journal 10/25/2006
Pfizer to Cut 20% Of U.S. Sales Force, Signaling End of Era - WSJ.com
Wall Street Journal 11/29/2006
AstraZeneca Vows to Work With FDA - WSJ.com
Wall Street Journal 11/28/2006
Cephalon Used Improper Tactics To Sell Drug, Probe Finds - WSJ.com
Wall Street Journal 11/21/2006
Taking Risk for Profit, Industry Seeks Cancer Drugs
New York Times 09/02/2009
Acquisitions and acquisition strategies of pharmaceutical companies.
02/09/2006
As growth slows pharmaceutical companies look to acquisitions for growth and new drugs.
Grouped Articles
Indian Drug Maker Vies for Betapharm
Wall Street Journal 02/09/2006
BusinessWeek 12/05/2007
CEO Says Aging Population Part of Allure of Eye-Care Acquisition
Wall Street Journal 04/08/2008
Wall Street Journal 01/24/2009
Wall Street Journal 03/02/2009
For Drug Deals, Small Is Beautiful
Wall Street Journal 03/12/2009
Pfizer.
01/19/2006
Grouped Articles
Wall Street Journal 01/19/2006
Weak Sales Prompt Pfizer to Cancel Diabetes Drug
New York Times 10/19/2007
Pfizer Unit, UCB Form a Venture
Wall Street Journal 10/21/2008
Drug Makers, Facing Critics, Will Stop Some Ads
Wall Street Journal 12/11/2008
Pfizer Plans to Lay Off Up to 2,400 in Sales
Wall Street Journal 01/17/2009
Pfizer Deal to Buy Wyeth Leaves Doubts
Wall Street Journal 01/27/2009
Western pharmaceutical company growth strategies.
07/09/2007
As sales growth slows in developed countries, pricing drops, and drug development is weak, the search for new avenues for growth.
Grouped Articles
Glaxo's Garnier Is Taking the Heat
Wall Street Journal 07/09/2007
Glaxo to Weigh Results Of New Diet Pill
Wall Street Journal 10/24/2007
Prescription-Drug Sales Growth Is Expected to Slow
Wall Street Journal 11/01/2007
BusinessWeek 12/05/2007
Osteoporosis Drug Is Amgen's Hope For a Strong Future
Wall Street Journal 12/14/2007
Glaxo Becomes Master of Reinventing Drugs
Wall Street Journal 04/17/2008
The new attractiveness of vaccines for drug companies.
02/23/2009
Vaccines represent a steady stream of reliable revenues for drug companies. They are also in great demand in high growth emerging markets like Brazil and China and help form relationships in these countries.
Grouped Articles
Wall Street Journal 02/23/2009
U.S. Drug Companies Chase Vaccines
Wall Street Journal 09/29/2009
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us
